PDB code | Main view | Title | 1bmq | | CRYSTAL STRUCTURE OF THE COMPLEX OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE) WITH A PEPTIDE BASED INHIBITOR, (3S )-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L-PROLYL }AMINO)-4-OXOBUTANAMIDE |
1cp3 | | CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC |
1f1j | | CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO |
1f9e | | CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO |
1gfw | | THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR CPP32)IN COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR. |
1gqf | | Crystal structure of human procaspase-7 |
1i3o | | CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3 |
1i4e | | CRYSTAL STRUCTURE OF THE CASPASE-8/P35 COMPLEX |
1i4o | | CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX |
1i51 | | CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP |
1ibc | | CRYSTAL STRUCTURE OF INHIBITED INTERLEUKIN-1BETA CONVERTING ENZYME |
1ice | | STRUCTURE AND MECHANISM OF INTERLEUKIN-1BETA CONVERTING ENZYME |
1jxq | | Structure of cleaved, CARD domain deleted Caspase-9 |
1k86 | | Crystal structure of caspase-7 |
1k88 | | Crystal structure of procaspase-7 |
1kmc | | Crystal Structure of the Caspase-7 / XIAP-BIR2 Complex |
1m72 | | Crystal Structure of Caspase-1 from Spodoptera frugiperda |
1nme | | Structure of Casp-3 with tethered salicylate |
1nmq | | Extendend Tethering: In Situ Assembly of Inhibitors |
1nms | | Caspase-3 tethered to irreversible inhibitor |
1nw9 | | STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP-BIR3 |
1pau | | CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO |
1pyo | | Crystal Structure of Human Caspase-2 in Complex with Acetyl-Leu-Asp-Glu-Ser-Asp-cho |
1qdu | | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK |
1qtn | | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE |
1qx3 | | Conformational restrictions in the active site of unliganded human caspase-3 |
1re1 | | CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR |
1rhj | | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR |
1rhk | | Crystal structure of the complex of caspase-3 with a phenyl-propyl-ketone inhibitor |
1rhm | | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR |
1rhq | | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR |
1rhr | | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR |
1rhu | | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 5,6,7 TRICYCLIC PEPTIDOMIMETIC INHIBITOR |
1rwk | | Crystal structure of human caspase-1 in complex with 3-(2-mercapto-acetylamino)-4-oxo-pentanoic acid |
1rwm | | Crystal structure of human caspase-1 in complex with 4-oxo-3-[2-(5-{[4-(quinoxalin-2-ylamino)-benzoylamino]-methyl}-thiophen-2-yl)-acetylamino]-pentanoic acid |
1rwn | | Crystal structure of human caspase-1 in complex with 3-{2-ethyl-6-[4-(quinoxalin-2-ylamino)-benzoylamino]-hexanoylamino}-4-oxo-butyric acid |
1rwo | | Crystal structure of human caspase-1 in complex with 4-oxo-3-{6-[4-(quinoxalin-2-ylamino)-benzoylamino]-2-thiophen-2-yl-hexanoylamino}-pentanoic acid |
1rwp | | Crystal structure of human caspase-1 in complex with 3-{6-[(8-hydroxy-quinoline-2-carbonyl)-amino]-2-thiophen-2-yl-hexanoylamino}-4-oxo-butyric acid |
1rwv | | Crystal structure of human caspase-1 in complex with 5-[5-(1-carboxymethyl-2-oxo-propylcarbamoyl)-5-phenyl-pentylsulfamoyl]-2-hydroxy-benzoic acid |
1rww | | Crystal structure of human caspase-1 in complex with 4-oxo-3-[(6-{[4-(quinoxalin-2-ylamino)-benzoylamino]-methyl}-pyridine-3-carbonyl)-amino]-butyric acid |
1rwx | | Crystal structure of human caspase-1 in complex with 4-oxo-3-{6-[4-(quinoxalin-2-yloxy)-benzoylamino]-2-thiophen-2-yl-hexanoylamino}-butyric acid |
1sc1 | | Crystal structure of an active-site ligand-free form of the human caspase-1 C285A mutant |
1sc3 | | Crystal structure of the human caspase-1 C285A mutant in complex with malonate |
1sc4 | | Crystal structure of the human caspase-1 C285A mutant after removal of malonate |
1shj | | Caspase-7 in complex with DICA allosteric inhibitor |
1shl | | CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR |
2ar9 | | Crystal structure of a dimeric caspase-9 |
2c1e | | Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors. |
2c2k | | Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors. |
2c2m | | Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors. |
2c2o | | Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors. |
2c2z | | Crystal structure of caspase-8 in complex with aza-peptide Michael acceptor inhibitor |
2cdr | | Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. |
2cjx | | Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis |
2cjy | | Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis |
2cnk | | Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. |
2cnl | | Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. |
2cnn | | Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. |
2cno | | Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. |
2dko | | Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis |
2fp3 | | Crystal structure of the Drosophila initiator caspase Dronc |
2fqq | | Crystal structure of human caspase-1 (Cys285->Ala, Cys362->Ala, Cys364->Ala, Cys397->Ala) in complex with 1-methyl-3-trifluoromethyl-1H-thieno[2,3-c]pyrazole-5-carboxylic acid (2-mercapto-ethyl)-amide |
2fun | | alternative p35-caspase-8 complex |
2h48 | | Crystal structure of human caspase-1 (Cys362->Ala, Cys364->Ala, Cys397->Ala) in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2h4w | | Crystal structure of human caspase-1 (Glu390->Asp) in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2h4y | | Crystal structure of human caspase-1 (Arg286->Lys) in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2h51 | | Crystal structure of human caspase-1 (Glu390->Asp and Arg286->Lys) in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2h54 | | Crystal structure of human caspase-1 (Thr388->Ala) in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2h5i | | Crystal structure of caspase-3 with inhibitor Ac-DEVD-Cho |
2h5j | | Crystal strusture of caspase-3 with inhibitor Ac-DMQD-Cho |
2h65 | | Crystal strusture of caspase-3 with inhibitor Ac-VDVAD-Cho |
2hbq | | Crystal structure of wildtype human caspase-1 in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2hbr | | Crystal structure of human caspase-1 (Arg286->Ala) in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2hby | | Crystal structure of human caspase-1 (Glu390->Ala) in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2hbz | | Crystal structure of human caspase-1 (Arg286->Ala, Glu390->Ala) in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
2j30 | | The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of (Pro)caspase-3 |
2j31 | | The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of(Pro)caspase-3 |
2j32 | | The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of(Pro)caspase-3 |
2j33 | | The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of (Pro)caspase-3 |
2k7z | | Solution Structure of the Catalytic Domain of Procaspase-8 |
2nn3 | | structure of pro-sf-caspase-1 |
2p2c | | Inhibition of caspase-2 by a designed ankyrin repeat protein (DARPin) |
2ql5 | | Crystal Structure of caspase-7 with inhibitor AC-DMQD-CHO |
2ql7 | | Crystal Structure of Caspase-7 with inhibitor AC-IEPD-CHO |
2ql9 | | Crystal Structure of Caspase-7 with inhibitor AC-DQMD-CHO |
2qlb | | Crystal Structure of caspase-7 with inhibitor AC-ESMD-CHO |
2qlf | | Crystal Structure of Caspase-7 with inhibitor AC-DNLD-CHO |
2qlj | | Crystal Structure of Caspase-7 with Inhibitor AC-WEHD-CHO |
2wdp | | Crystal Structure of Ligand Free Human Caspase-6 |
2xyg | | Caspase-3:CAS329306 |
2xyh | | Caspase-3:CAS60254719 |
2xyp | | Caspase-3:CAS26049945 |
2xzd | | Caspase-3 in Complex with an Inhibitory DARPin-3.4 |
2xzt | | Caspase-3 in Complex with DARPin-3.4_I78S |
2y0b | | Caspase-3 in Complex with an Inhibitory DARPin-3.4_S76R |
2y1l | | Caspase-8 in Complex with DARPin-8.4 |
3d6f | | Crystal structure of human caspase-1 with a naturally-occurring Arg240->Gln substitution in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
3d6h | | Crystal structure of human caspase-1 with a naturally-occurring Asn263->Ser substitution in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
3d6m | | Crystal structure of human caspase-1 with a naturally-occurring Lys319->Arg substitution in complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) |
3deh | | Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors |
3dei | | Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors |
3dej | | Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors |
3dek | | Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors |
3e4c | | Procaspase-1 zymogen domain crystal strucutre |
3edq | | Crystal structure of Caspase-3 with inhibitor AC-LDESD-CHO |
3edr | | The crystal structure of caspase-7 in complex with Acetyl-LDESD-CHO |
3gjq | | Caspase-3 Binds Diverse P4 Residues in Peptides |
3gjr | | Caspase-3 Binds Diverse P4 Residues in Peptides |
3gjs | | Caspase-3 Binds Diverse P4 Residues in Peptides |
3gjt | | Caspase-3 Binds Diverse P4 Residues in Peptides |
3h0e | | 3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as Potent Non-Peptidic Inhibitors of Caspase-3 |
3h11 | | Zymogen caspase-8:c-FLIPL protease domain complex |
3h13 | | c-FLIPL protease-like domain |
3h1p | | Mature Caspase-7 I213A with DEVD-CHO inhibitor bound to active site |
3ibc | | Crystal Structure of Caspase-7 incomplex with Acetyl-YVAD-CHO |
3ibf | | Crystal structure of unliganded caspase-7 |
3itn | | Crystal structure of Pseudo-activated Procaspase-3 |
3j9k | | 3J9K |
3k7e | | Crystal structure of human ligand-free mature caspase-6 |
3kjf | | Caspase 3 Bound to a covalent inhibitor |
3kjn | | Caspase 8 bound to a covalent inhibitor |
3kjq | | Caspase 8 with covalent inhibitor |
3nkf | | Crystal structure of human ligand-free mature caspase-6 with intersubunit linker attached |
3nr2 | | Crystal structure of Caspase-6 zymogen |
3ns7 | | Succinic Acid Amides as P2-P3 Replacements for Inhibitors of Interleukin-1beta Converting Enzyme (ICE or Caspase 1) |
3od5 | | Crystal structure of active caspase-6 bound with Ac-VEID-CHO |
3p45 | | Crystal structure of apo-caspase-6 at physiological pH |
3p4u | | Crystal structure of active caspase-6 in complex with Ac-VEID-CHO inhibitor |
3pcx | | Caspase-3 E246A, K242A Double Mutant |
3pd0 | | Caspase-3 E246A |
3pd1 | | Caspase-3 K242A |
3qnw | | Caspase-6 in complex with Z-VAD-FMK inhibitor |
3r5j | | Crystal structure of active caspase-2 bound with Ac-ADVAD-CHO |
3r5k | | A designed redox-controlled caspase-7 |
3r6g | | Crystal structure of active caspase-2 bound with Ac-VDVAD-CHO |
3r6l | | Caspase-2 T380A bound with Ac-VDVAD-CHO |
3r7b | | Caspase-2 bound to one copy of Ac-DVAD-CHO |
3r7n | | Caspase-2 bound with two copies of Ac-DVAD-CHO |
3r7s | | Crystal Structure of Apo Caspase2 |
3rjm | | CASPASE2 IN COMPLEX WITH CHDI LIGAND 33c |
3s70 | | Crystal structure of active caspase-6 bound with Ac-VEID-CHO solved by As-SAD |
3s8e | | Phosphorylation regulates assembly of the caspase-6 substrate-binding groove |
3sip | | Crystal structure of drICE and dIAP1-BIR1 complex |
3sir | | Crystal Structure of drICE |
3uo8 | | Crystal structure of the MALT1 paracaspase (P1 form) |
3uoa | | Crystal structure of the MALT1 paracaspase (P21 form) |
3v3k | | Human caspase 9 in complex with bacterial effector protein |
3v4o | | Human MALT1 (caspase domain) in complex with an irreversible peptidic inhibitor |
3v55 | | Human MALT1 (334-719) in its ligand free form |
3v6l | | Crystal Structure of caspase-6 inactivation mutation |
3v6m | | Inhibition of caspase-6 activity by single mutation outside the active site |
4dcj | | Crystal structure of caspase 3, L168D mutant |
4dco | | Crystal Structure of caspase 3, L168Y mutant |
4dcp | | Crystal Structure of caspase 3, L168F mutant |
4eha | | Allosteric Modulation of Caspase-3 through Mutagenesis |
4ehd | | Allosteric Modulation of Caspase-3 through Mutagenesis |
4ehf | | Allosteric Modulation of Caspase-3 through Mutagenesis |
4ehh | | Allosteric Modulation of Caspase-3 through Mutagenesis |
4ehk | | Allosteric Modulation of Caspase-3 through Mutagenesis |
4ehl | | Allosteric Modulation of Caspase-3 through Mutagenesis |
4ehn | | Allosteric Modulation of Caspase-3 through Mutagenesis |
4ejf | | Allosteric peptides that bind to a caspase zymogen and mediate caspase tetramerization |
4fdl | | Crystal structure of Caspase-7 |
4fea | | Crystal structure of CASPASE-7 in Complex with allosteric inhibitor |
4fxo | | Zinc-mediated allosteric inhibiton of caspase-6 |
4hq0 | | Crystal Structure of mutant form of Caspase-7 |
4hqr | | Crystal Structure of mutant form of Caspase-7 |
4hva | | Mechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6 |
4i1p | | 4I1P |
4i1r | | Human MALT1 (caspase-IG3) in complex with thioridazine |
4iyr | | Crystal structure of full-length caspase-6 zymogen |
4jb8 | | Caspase-7 in Complex with DARPin C7_16 |
4jj7 | | Caspase-3 specific unnatural amino acid-based peptides |
4jj8 | | Caspase-3 specific unnatural amino acid peptides |
4jje | | Caspase-3 specific unnatural amino acid peptides |
4jqy | | Human procaspase-3, crystal form 1 |
4jqz | | Human procaspase-3, crystal form 2 |
4jr0 | | Human procaspase-3 bound to Ac-DEVD-CMK |
4jr1 | | Human procaspase-7 bound to Ac-DEVD-CMK |
4jr2 | | Human procaspase-7/caspase-7 heterodimer bound to Ac-DEVD-CMK |
4lsz | | 4LSZ |
4m9r | | Crystal structure of CED-3 |
4n5d | | Tailoring Small Molecules for an Allosteric Site on Procaspase-6: Cpd1 |
4n6g | | Tailoring Small Molecules for an Allosteric Site on Procaspase-6 |
4n7j | | Tailoring Small Molecules for an Allosteric Site on Procaspase-6 |
4n7m | | Tailoring Small Molecules for an Allosteric Site on Procaspase-6 |
4nbk | | Tailoring Small Molecules for an Allosteric Site on Procaspase-6 |
4nbl | | Tailoring Small Molecules for an Allosteric Site on Procaspase-6 |
4nbn | | Tailoring Small Molecules for an Allosteric Site on Procaspase-6 |
4pry | | 4PRY |
4prz | | 4PRZ |
4ps0 | | 4PS0 |
4ps1 | | 4PS1 |
4qtx | | 4QTX |
4qty | | 4QTY |
4qu0 | | 4QU0 |
4qu5 | | 4QU5 |
4qu8 | | 4QU8 |
4qu9 | | 4QU9 |
4qua | | 4QUA |
4qub | | 4QUB |
4qud | | 4QUD |
4que | | 4QUE |
4qug | | 4QUG |
4quh | | 4QUH |
4qui | | 4QUI |
4quj | | 4QUJ |
4qul | | 4QUL |
4zvo | | 4ZVO |
4zvp | | 4ZVP |
4zvq | | 4ZVQ |
4zvr | | 4ZVR |
4zvs | | 4ZVS |
4zvt | | 4ZVT |
4zvu | | 4ZVU |
5i9b | | 5I9B |
5i9t | | 5I9T |
5iab | | 5IAB |
5iae | | 5IAE |
5iag | | 5IAG |
5iaj | | 5IAJ |
5iak | | 5IAK |
5ian | | 5IAN |
5iar | | 5IAR |
5ias | | 5IAS |
5ibc | | 5IBC |
5ibp | | 5IBP |
5ibr | | 5IBR |
5ic4 | | 5IC4 |
5ic6 | | 5IC6 |
5jft | | 5JFT |